Matthew Sinnreich - Jul 21, 2022 Form 3 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Signature
/s/ Matthew Sinnreich
Stock symbol
OCEL
Transactions as of
Jul 21, 2022
Transactions value $
$0
Form type
3
Date filed
7/26/2022, 04:05 PM
Next filing
Oct 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OCEL Common Stock, $0.001 par value 10M Jul 21, 2022 Direct F1
holding OCEL Common Stock, $0.001 par value 24M Jul 21, 2022 Direct F2
holding OCEL Common Stock, $0.001 par value 7M Jul 21, 2022 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OCEL Warrants to Purchase Common Stock Jul 21, 2022 Common Stock, par value $0.001 per share 40M $0.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock and warrants to purchase common stock issued to the Reporting Person as a signing bonus in connection with his employment as the Issuer's Chief Operating Officer and Acting Chief Executive Officer.
F2 Represents shares of common stock issued to the Reporting Person as compensation during for his first year of employment. The shares vest in twelve monthly installments of 2,000,000 shares each, subject to continued employment.
F3 Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.